Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Evaluation of HeartPoint Global Intellistent for Pulmonary Flow Adjustment in Congenital Heart Disease and Dilated Cardiomyopathy

NCT06072937 is registered in ClinicalTrials.gov with HeartPoint Global as lead sponsor.

NCT NCT06072937
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06072937 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Evaluation of HeartPoint Global Intellistent for Pulmonary Flow Adjustment in Congenital Heart Disease and Dilated Cardiomyopathy
Lead sponsor
HeartPoint Global
Phase
Not applicable
Overall status
Unknown status
Start date
June 4, 2024
Completion date
June 4, 2026
Enrollment
10 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

congenital heart disease, dilated cardiomyopathy, pulmonary arterial hypertension